Search for: "ELI LILLY & CO." Results 601 - 620 of 1,009
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2010, 4:47 pm
Patent for Induced Pluripotent Stem Cell Technology (Patent Docs)   Products Actos (Pioglitazone) –US:Patent infringement complaint filed following a Paragraph IV certification: Takeda Pharmaceutical Co. et al. v. [read post]
25 May 2011, 8:52 pm by Aaron Barkoff
 From the pharmaceutical industry, amicus briefs were filed by Apotex; Sanofi-Aventis; Eli Lilly & Co.; BIO; Eisai; Johnson & Johnson; PhRMA; Teva; and GPhA. [read post]
9 Sep 2010, 7:09 pm
We reached the same result in Eli Lilly & Co. v. [read post]
5 Feb 2009, 6:32 am
Well-known antidepressants include Eli Lilly and Co's (LLY.N) Prozac, Pfizer Inc's (PFE.N) Zoloft, GlaxoSmithKline Plc's (GSK.L)(GSK.N) Paxil and Forest Laboratories Inc's (FRX.N) Lexapro and Celexa. [read post]
30 Nov 2011, 3:45 pm by admin
The same year, Eli Lilly & Co. paid $1.4 billion in a settlement concerning sales of its Zyprexa anti-psychotic medicine. [read post]
7 Sep 2010, 12:25 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
4 Jan 2021, 9:04 pm by Dan Flynn
Ractopamine is owned by Elanco, a subsidiary of the pharmaceutical company Eli Lilly and Co. [read post]
21 May 2014, 7:41 am by Larisa Vaysman
Eli Lilly & Co., 592 F.2d 317, 319 (6th Cir. 1979) (“This is not the first time our questions have been rebuffed by the Michigan Supreme Court . . . . [read post]
12 Oct 2010, 8:56 pm by Kelly
Apotex asks Supreme Court to review generic Cozaar/Hyzaar 180-day exclusivity decision (FDA Law Blog) Faslodex (Fulvestrant) – US: AstraZeneca seeks review of BPAI decision concerning patent covering ‘Use of Fulvestrant in treatment of resistant breast cancer’ (Patent Docs) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against Dr Reddy’s following Para IV certification (Patent Docs) Lipitor (Atorvastatin) – US: Generic… [read post]
4 Sep 2012, 7:31 am by arester
Skadden, Arps, Slate, Meagher & Flom LLP was hired by Amylin to perform delicate corporate surgery, first extracting the diabetes-drug developer—along with, Bydureon, its most valuable drug—from a soured pact with Eli Lilly & Co. and then helping to sell the company to Bristol-Myers Squibb Co. in a $5.1 billion deal that closed in August... [read post]
30 Jan 2012, 8:11 pm
She is blaming 14 drug manufacturers, including Bristol-Myers Squibb Co. and Eli Lilly and Co,. for not letting the FDA and doctors know that DES came with serious safety risks and actually did not stop miscarriages from happening. [read post]
5 Mar 2009, 10:22 am
Byetta is a diabetes drug co-marketed in the U.S. by Amylin Pharmaceuticals Inc., based in San Diego, and Eli Lilly & Co., of Indianapolis. [read post]